The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin

The 2 histone deacetylase inhibitors (HDACIs) approved for the treatment of cutaneous T-cell lymphoma (CTCL) including mycosis fungoides/sezary syndrome (MF/SS), suberoylanilide hydroxamic acid (SAHA) and romidepsin, are associated with low rates of overall response and high rates of adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyal, Lilach, Feldbaum, Nataly, Goldfeiz, Neta, Rephaeli, Ada, Nudelman, Abraham, Weitman, Michal, Tarasenko, Nataly, Gorovitz, Batia, Maron, Leah, Yehezkel, Shiran, Amitay-Laish, Iris, Lubin, Ido, Hodak, Emmilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709199/
https://www.ncbi.nlm.nih.gov/pubmed/26752418
http://dx.doi.org/10.1371/journal.pone.0146115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709199/
https://www.ncbi.nlm.nih.gov/pubmed/26752418
http://dx.doi.org/10.1371/journal.pone.0146115

Ejemplares similares